Integrated BioPharma (OTCMKTS:INBP) Stock Price Up 0.4% – What’s Next?

Shares of Integrated BioPharma, Inc. (OTCMKTS:INBP) were up 0.4% during mid-day trading on Monday . The stock traded as high as $0.33 and last traded at $0.32. 42,400 shares were traded during trading, an increase of 305% from the average daily volume of 10,462 shares. The stock had previously closed at $0.32.

Integrated BioPharma Stock Performance

The stock has a market capitalization of $9.67 million, a P/E ratio of 15.97 and a beta of 0.59. The business has a 50-day moving average price of $0.31 and a 200 day moving average price of $0.25.

Integrated BioPharma (OTCMKTS:INBP) last released its earnings results on Friday, September 20th. The company reported $0.01 EPS for the quarter. Integrated BioPharma had a return on equity of 2.26% and a net margin of 0.84%. The business had revenue of $12.75 million for the quarter.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.